-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Natural Killer Cells: A New Frontier for Cancer Immunotherapy

Program: General Sessions
Session: E. Donnall Thomas Lecture and Prize
Monday, December 11, 2023, 9:00 AM-10:00 AM

Katy Rezvani, MD

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M D Anderson Cancer Center, Houston, TX

Disclosures: Rezvani: Takeda: Patents & Royalties; Affimed: Other: License agreement.